Philadelphia, PA, United States of America

Andrew Wechsler

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 8.0

ph-index = 4

Forward Citations = 112(Granted Patents)


Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations in Cardiac Treatment: The Patented Contributions of Andrew Wechsler

Introduction: Andrew Wechsler, an accomplished inventor based in Philadelphia, PA, has made significant strides in the field of medical device innovation. With a total of seven patents to his name, his work primarily focuses on developing advanced solutions for treating congestive heart failure (CHF) and related conditions. As a key member of Bioventrix, Inc., Wechsler continues to push the boundaries of minimally invasive cardiac therapies.

Latest Patents: Among his notable contributions are two groundbreaking patents. The first patent outlines an "Over-the-wire cardiac implant delivery system for treatment of CHF and other conditions." This innovative medical device is designed to minimize invasive procedures by reducing the distance between two sites in cardiac tissue. In this system, an anchor is placed within the right ventricle, engaging with the ventricular septum. A tension member extends from the anchor through the septum into the left ventricle, facilitating efficient delivery of the implant via a guidewire.

The second patent focuses on "Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditions." This invention describes techniques for reshaping the ventricular chamber by controlling the deployment of an anchor from both the epicardial and right atrial pathways. This dual-access approach enhances the precision and effectiveness of treatment, promising improved outcomes for patients suffering from heart conditions.

Career Highlights: Throughout his career, Andrew Wechsler has demonstrated exceptional ingenuity and expertise in the medical devices sector. His work at Bioventrix, Inc. has positioned him as a leader in the development of minimally invasive cardiac technologies. His seven patents reflect his commitment to improving healthcare through innovative solutions.

Collaborations: Wechsler's success is further aided by his collaboration with colleagues such as Kevin H. Van Bladel and Lon S. Annest. Their combined efforts contribute to advancing the field of cardiac treatments, enhancing the potential for groundbreaking innovations.

Conclusion: Andrew Wechsler's contributions to the realm of cardiac health exemplify the vital role of inventors in shaping modern medicine. With his ongoing work at Bioventrix, Inc. and a portfolio of significant patents, he remains at the forefront of innovations aimed at improving treatment strategies for congestive heart failure and related cardiac conditions. His commitment to advancing medical technology ensures that he will be a key figure in transforming patient care for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…